Analysts were nearly all impressed by Biogen and Eisai’s positive results from a mid-stage trial of an Alzheimer’s treatment. But Leerink was a dissenter.
Source: MarketWatch Stories
Posted from my blog with SteemPress : https://networkurl.com/story-asp-2239
This user is on the @buildawhale blacklist for one or more of the following reasons:
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Submit